Evidence map›Paper›PMID 25732599›Full record

ArticleScientific reports2015

Anthracycline-containing chemotherapy causes long-term impairment of mitochondrial respiration and increased reactive oxygen species release in skeletal muscle.

Gilles Gouspillou, Celena Scheede-Bergdahl, Sally Spendiff, Madhusudanarao Vuda, Brian Meehan, Heather Mlynarski, Elodie Archer-Lahlou, Nicolas Sgarioto, Fennigje M Purves-Smith, Yana Konokhova and 5 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04467411 (Randomised Controlled Study of Physical Exercise Intervention in Breast Cancer Patients at Risk of Anthracycline-induced Cardiomyopathy), which is not on this map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
17.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04467411 active not recruitingnot on this mapstarted 2020, after this paper: background citation

Randomised Controlled Study of Physical Exercise Intervention in Breast Cancer Patients at Risk of Anthracycline-induced Cardiomyopathy:The EMBRACE Study

TypeobservationalSponsorUniversity of AberdeenRan2020 to 2030Enrolled70ConditionsBreast Cancer
3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 74 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Factors affecting pretransplant muscle strength in allogeneic stem cell transplant candidates prior transplantation.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  8. Cancer Cachexia.Advances in experimental medicine and biology · 2025
    Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Effects of Voluntary Wheel Running Exercise on Chemotherapy-Impaired Cognitive and Motor Performance in Mice.International journal of environmental research and public health · 2023
    Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Gilles Gouspillou1] McGill University Health Centre, Montreal, Quebec, Canada [2] Département de Kinanthropologie, Université du Québec à Montréal, Montreal, Quebec, Canada.
Celena Scheede-Bergdahl1] Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada [2] Department of Kinesiology, McGill University, Montreal, Quebec, Canada.
Sally Spendiff1] McGill University Health Centre, Montreal, Quebec, Canada [2] Department of Kinesiology, McGill University, Montreal, Quebec, Canada.
Madhusudanarao VudaMcGill University Health Centre, Montreal, Quebec, Canada.
Brian Meehan1] Department of Oncology, McGill University, Montreal, Quebec, Canada [2] Montreal Children's Hospital Research Institute, Montreal, Quebec, Canada.
Heather MlynarskiLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
Elodie Archer-LahlouLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
Nicolas SgariotoMcGill University Health Centre, Montreal, Quebec, Canada.
Fennigje M Purves-Smith1] McGill University Health Centre, Montreal, Quebec, Canada [2] Department of Kinesiology, McGill University, Montreal, Quebec, Canada.
Yana Konokhova1] McGill University Health Centre, Montreal, Quebec, Canada [2] Department of Kinesiology, McGill University, Montreal, Quebec, Canada.
Janusz Rak1] Department of Oncology, McGill University, Montreal, Quebec, Canada [2] Montreal Children's Hospital Research Institute, Montreal, Quebec, Canada.
Stéphanie ChevalierMcGill University Health Centre, Montreal, Quebec, Canada.
Tanja TaivassaloDepartment of Kinesiology, McGill University, Montreal, Quebec, Canada.
Russell T Hepple1] McGill University Health Centre, Montreal, Quebec, Canada [2] Department of Kinesiology, McGill University, Montreal, Quebec, Canada.
R Thomas Jagoe1] Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada [2] Department of Oncology, McGill University, Montreal, Quebec, Canada.
McGill University Health Centre · CAJewish General Hospital · CAMcGill University · CA

Funding

Canadian Institutes of Health Research 111119Canadian Institutes of Health Research 119583
6 · The paper itself

Abstract

Anticancer treatments for childhood acute lymphoblastic leukaemia (ALL) are highly effective but are now implicated in causing impaired muscle function in long-term survivors. However, no comprehensive assessment of skeletal muscle mitochondrial functions in long-term survivors has been performed and the presence of persistent chemotherapy-induced skeletal muscle mitochondrial dysfunction remains a strong possibility. Non-tumour-bearing mice were treated with two drugs that have been used frequently in ALL treatment (doxorubicin and dexamethasone) for up to 4 cycles at 3-week intervals and euthanized 3 months after the 4th cycle. Treated animals had impaired growth and lower muscle mass as well as reduced mitochondrial respiration and increased reactive oxygen species production per unit oxygen consumption. Mitochondrial DNA content and protein levels of key mitochondrial membrane proteins and markers of mitochondrial biogenesis were unchanged, but protein levels of Parkin were reduced. This suggests a novel pattern of chemotherapy-induced mitochondrial dysfunction in skeletal muscle that persists because of an acquired defect in mitophagy signaling. The results could explain the observed functional impairments in adult survivors of childhood ALL and may also be relevant to long-term survivors of other cancers treated with similar regimes.

Indexed as

AnimalsAnthracyclinesAntineoplastic AgentsCell RespirationDexamethasoneDNA, MitochondrialDoxorubicinFemaleMiceMitochondria, MuscleMitophagyMuscle, SkeletalMutationOxidative StressReactive Oxygen SpeciesSequence DeletionAnthracyclinesAntineoplastic AgentsDexamethasoneDNA, MitochondrialDoxorubicinReactive Oxygen Species

Identifiers

PMID25732599
PMCPMC4346812
OpenAlexW2046189491

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.